Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Sboner A, Aliferis CF. Modeling clinical judgment and implicit guideline compliance in the diagnosis of melanomas using machine learning. AMIA Annu Symp Proc. 2005:664-8.

Ito K, Chen J, Seshan SV, Khodadadian JJ, Gallagher R, Chaar ME, et al. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int. 2005;68(2):515-28.

Jaggi JS, Seshan SV, McDevitt MR, LaPerle K, Sgouros G, Scheinberg DA. Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters. J Am Soc Nephrol. 2005;16(9):2677-89.

Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu M-, et al. Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res. 2005;11(24 Pt 1):8623-31.

Wai CY, Nihira MA, Drewes PG, Chang JS, Siddiqui MT, Hemsell DL. Actinomyces associated with persistent vaginal granulation tissue. Infect Dis Obstet Gynecol. 2005;13(1):53-5.

Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, et al. The transcriptional landscape of the mammalian genome. Science. 2005;309(5740):1559-63.

2004

Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004;303(5663):1522-6.

Magro CM, Nuovo G, Ferri C, A Crowson N, Giuggioli D, Sebastiani M. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol. 2004;31(1):43-50.

Parihar R, Nadella P, Lewis A, Jensen R, De Hoff C, Dierksheide JE, et al. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res. 2004;10(15):5027-37.

Xi Z, Klokk TI, Korkmaz K, Kurys P, Elbi C, Risberg B, et al. Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res. 2004;64(7):2365-70.